Evidence map›Paper›PMID 37759231›Full record

ArticleAlzheimer's research & therapy2023

Correction: Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment.

Andreas Giannisis, Asma Al-Grety, Henrik Carlsson, Jennifer C Howell, William T Hu, Kim Kultima, Henrietta M Nielsen

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Alzheimer's research & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Andreas GiannisisDepartment of Biochemistry and Biophysics, Stockholm University, Svante Arrhenius Väg 16B, 114 18, Stockholm, Sweden.
Asma Al-GretyDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Henrik CarlssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Jennifer C HowellDepartment of Neurology, Emory University, Atlanta, GA, USA.
William T HuDepartment of Neurology, Emory University, Atlanta, GA, USA.
Kim KultimaDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Henrietta M NielsenDepartment of Biochemistry and Biophysics, Stockholm University, Svante Arrhenius Väg 16B, 114 18, Stockholm, Sweden. henrietta.nielsen@dbb.su.se.

Funding

CSF, MRI, and PET biomarkers of neuroinflammation in Alzheimer's diseaseR01AG054046 · NIA · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI HU, WILLIAM TZU-LUNG · 2016 to 2020
$3.9M
Transfer RF1 AG054991 Beyond Haploinsuffiency- Gain of Function in Prograulin MutationsRF1AG054991 · NIA · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI HU, WILLIAM TZU-LUNG · 2019 to 2019
$3.4M
African American Alzheimer's Progression Markers - CSF and Neuro-ImagingR21AG043885 · NIA · EMORY UNIVERSITY · PI HU, WILLIAM TZU-LUNG · 2013 to 2014
$429k
NIA NIH HHS R01 AG054046NIA NIH HHS R21 AG043885NIA NIH HHS RF1 AG054991
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37759231
PMCPMC10523732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.